Finance
Finance
Home002294 • SHE
Shenzhen Salubris Pharmaceuticals Co Ltd
¥61.88
Mar 27, 2:15:54 PM GMT+8 · CNY · SHE · Disclaimer
StockCN listed security
Previous close
¥56.25
Day range
¥55.80 - ¥61.88
Year range
¥29.80 - ¥65.63
Market cap
63.60B CNY
Avg Volume
8.08M
P/E ratio
102.57
Dividend yield
0.81%
Primary exchange
SHE
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Sep 2025Y/Y change
Revenue
1.11B15.85%
Operating expense
595.66M12.44%
Net income
215.63M30.19%
Net profit margin
19.4212.38%
Earnings per share
EBITDA
325.52M20.69%
Effective tax rate
7.72%
Total assets
Total liabilities
(CNY)Sep 2025Y/Y change
Cash and short-term investments
2.42B26.81%
Total assets
10.98B7.34%
Total liabilities
2.05B29.25%
Total equity
8.93B
Shares outstanding
1.11B
Price to book
7.15
Return on assets
5.45%
Return on capital
6.52%
Net change in cash
(CNY)Sep 2025Y/Y change
Net income
215.63M30.19%
Cash from operations
351.03M9.40%
Cash from investing
-236.28M55.75%
Cash from financing
24.83M-91.95%
Net change in cash
135.42M53.56%
Free cash flow
-881.51M27.65%
About
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company. Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019. Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Founded
Nov 3, 1998
Employees
3,596
Search
Clear search
Close search
Google apps
Main menu